new scrutiny of pharmacy compounding

The fungal meningitis outbreak in the U.S. will result in new scrutiny of pharmacy compounding.

We all know that compounding fills several important needs.

But it gets confusing when a compounder acts like a manufacturer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote